Prospective validation of a nomogram predictive of a positive initial prostate biopsy;Validación prospectiva de un nomograma predictivo de la presencia de cáncer de próstata en pacientes que se someten a biopsia transrectal ecodirigida de 10 cilindros

Actas Urologicas Espanolas

Volumn 34, Issue 1, 2010, Pages 35-42

  Ramirez Backhaus M ^a   Bahilo, P ^b   Arlandis, S ^b   Santamaria Navarro C ^c   Pontones Moreno, J L ^b   Jimenez Cruz F ^b  

^a Hospital Universitario de la Ribera   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

Author keywords

Nomogram; Prostate biopsy; Prostate cancer; Validation

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BLOOD; CALIBRATION; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; NOMOGRAM; PATHOLOGY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; PROSTATE; PROSTATE DISEASE; PROSTATE TUMOR; RETROSPECTIVE STUDY; THEORETICAL MODEL; VALIDATION STUDY;

AGED; BIOPSY, NEEDLE; CALIBRATION; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; MULTIVARIATE ANALYSIS; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC DISEASES; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 77952109209     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-4806(10)70008-5     Document Type: Article

References (22)

1. Chun F.K., Briganti A., Graefen M., Porter C., Montorsi F., Haese A., et al. Development and external validation of an extended repeat biopsy nomogram. J Urol 177 2 (2007) 510-515
2. Ramírez Backhaus M., Trassierra Villa M., Arlandis Guzman S., Delgado Oliva F., Boronat Tormo F., and Jiménez Cruz J.F. Estrategias para la biopsia se próstata. Revisión de la literatura. Actas Urol Esp 31 10 (2007) 1089-1099
3. Ramírez Backhaus M., Trassierra Villa M., Arlandis Guzman S., Bosquet Sanz M., Pontones Moreno J.L., and Jiménez Cruz J.F. Valor diagnóstico de los cilindros periféricos en las biopsias de 10 cilindros. Actas Urol Esp 31 1 (2007) 11-16
4. Pitts Jr. W.R. The clinical implications of the Prostate Cancer Prevention Trial (PCPT). BJU Int 93 7 (2004) 1120-1121
5. Snow P.B., Smith D.S., and Catalona W.J. Artificial neural networks in the diagnosis and prognosis of prostate cancer: a pilot study. J Urol 152 (1994) 1923-1926 5 Pt 2
6. Schroder F., and Kattan M.W. The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone: a systematic review. Eur Urol 54 2 (2008) 274-290
7. López-Corona E., Ohori M., Scardino P.T., Reuter V.E., Gonen M., and Kattan M.W. A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session. J Urol 170 4 Pt 1 (2003) 1184-1188
8. Yanke B.V., Gonen M., Scardino P.T., and Kattan M.W. Validation of a nomogram for predicting positive repeat biopsy for prostate cancer. J Urol 173 2 (2005) 421-424
9. Backhaus R.M., Villa T.M., Mateu B.P., Moreno P.J., Navarro S.C., Ruiz-Cerdá J.L., et al. Desarrollo de un Modelo Matemático preliminar para la detección de cáncer de próstata en los pacientes con biopsias prostáticas de repetición. Actas Urol Esp 32 3 (2008) 281-287
10. Chun F.K., Graefen M., Briganti A., Gallina A., Hopp J., Kattan M.W., et al. Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network. Eur Urol 51 5 (2007) 1236-1240
11. Eastham J.A., May R., Robertson J.L., Sartor O., and Kattan M.W. Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/ml. Urology 54 4 (1999) 709-713
12. Garzotto M., Hudson R.G., Peters L., Hsieh Y.C., Barrera E., Mori M., et al. Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels < or = 10 ng/ml. Cancer 98 7 (2003) 1417-1422
13. Karakievicz P.I., Benayoun S., Kattan M.W., Perrotte P., Valiquette L., Scardino P.T., et al. Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen. J Urol 173 6 (2005) 1930-1934
14. Chun F.K., Briganti A., Graefen M., Montorsi F., Porter C., Scattoni V., et al. Development and external validation of an extended 10-core biopsy nomogram. Eur Urol 52 2 (2007) 436-444
15. Remzi M., Fong Y.K., Dobrovits M., Anagnostou T., Seitz C., Waldert M., et al. The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume. J Urol 174 (2005) 1256-1260 4 Pt 1
16. Optenberg S.A., Clark J.Y., Brawer M.K., Thompson I.M., Stein C.R., and Friedrichs P. Development of a decision-making tool to predict risk of prostate cancer: the Cancer of the Prostate Risk Index (CAPRI) test. Urology 50 5 (1997) 665-672
17. Stephan C., Xu C., Cammann H., Graefen M., Haese A., Huland H., et al. Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 men. World J Urol 25 1 (2007) 95-103
18. Nam R.K., Toi A., Klotz L.H., Trachtenberg J., Jewett M.A., Loblaw A., et al. Nomogram prediction for prostate cancer and aggressive prostate cancer at time of biopsy: utilizing all risk factors and tumor markers for prostate cancer. Can J Urol 13 Suppl 2 (2006) 2-10
19. Thompson I.M., Pauler Ankerst D., Chi C., Goodman P.J., Tangen C.M., Lippman S.M., et al. Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial. J Clin Oncol 25 21 (2007) 3076-3081
20. Canto E.I., Singh H., Shariat S.F., Kadmon D., Miles B.J., Wheeler T.M., et al. Effects of systematic 12-core biopsy on the performance of percent free prostate specific antigen for prostate cancer detection. J Urol 172 3 (2004) 900-904
21. Huang Foen Chung J.W., de Vries S.H., Raaijmakers R., Postma R., Bosch J.L., and van Mastrigt R. Prostate volume ultrasonography: the influence of transabdominal versus transrectal approach, device type and operator. Eur Urol 46 3 (2004) 352-356
22. Martínez Jabaloyas J.M., Ruiz Cerdá J.L., Osca García J.M., Sanz Chinesta S., Boronat Tormo F., and Jiménez Cruz J.F. Ecografía vesico-prostática frente a planimetría transrectal para la determinación del volumen prostático. Actas Urol Esp 17 (1993)